EMS initiated Buprenorphine for Opioid Use Disorder

Funded by the NIH HEAL Initiative℠

Emergency Medical Services (EMS) encounters for opioid overdose and withdrawal offer a crucial touchpoint to initiate buprenorphine treatment and to increase treatment participation rates for persons with opioid use disorder (OUD). This project will develop and refine a prehospital EMS clinical field protocol to initiate buprenorphine in persons with OUD presenting with an overdose requiring naloxone rescue or acute opioid withdrawal. Employing a Delphi Consensus process and stakeholder focus groups; followed by a sequence of pragmatic controlled field studies, the study will provide preliminary feasibility, acceptability, and safety data. Finally, a multi-site, systematic, prospective evaluation trial will be conducted to assess the rates of engagement in continuation of medication for OUD post EMS initiation.
 

CTN Protocol ID: 
CTN-0154
Status: 
Development

Principal Investigator(s)

Gail D'Onofrio, M.D., M.S.

Professor of Emergency Medicine
Yale University School of Medicine
Chair, Department of Emergency Medicine

464 Congress Avenue
Suite 260
New Haven, CT 06519
United States

Andrew Herring, M.D.

Assistant Clinical Professor, UCSF and Associate Director of Research
Highland Hospital-Alameda Health System
Department of Emergency Medicine

1411 East 31st Street
Oakland, CA 94602
United States

Gerard Carroll, M.D., FAAEM, EMT-P

EMS Medical Director; Program Director, EMS Fellowship Program; Division Head of EMS/Disaster Medicine; Associate Professor of Emergency Medicine
Cooper Medical School of Rowan University

One Cooper Plaza
Camden, NJ 08103
United States